Company

Torrey Pines Medicine

Torrey Pines Medicine develops long-acting peptide drugs for metabolic diseases such as obesity and diabetes.

About

Founded in 2024, Torrey Pines Medicine develops peptide drugs for metabolic diseases such as obesity and diabetes, using AI, high-throughput screening, and structural biology. The company is based in Shenzhen, China. In July 2026, it raised Angel funding led by Lotus Lake Capital, with Star Capital, Taiyou, BOCG, and Shen Yousheng participating.

1Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in